Q4 2022 Earnings

Events

Investor Relations

Press Releases

28 Feb '24
Continues to Work Diligently Towards Regaining Compliance CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC
28 Feb '24
CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho , Veradigm interim Chief Executive Officer, and Lee Westerfield , interim Chief Financial Officer, will present at
27 Feb '24
Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan CHICAGO --(BUSINESS WIRE)--Feb. 27, 2024-- Veradigm Inc.
27 Feb '24
Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com